Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia

Published:2016-06 Issue:6 Volume:22 Page:1080-1086
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Xu Lan-Ping,Xu Zheng-Li,Zhang Xiao-Hui,Chen Huan,Chen Yu-Hong,Han Wei,Chen Yao,Wang Feng-Rong,Wang Jing-Zhi,Wang Yu,Yan Chen-Hua,Mo Xiao-Dong,Liu Kai-Yan,Huang Xiao-Jun

Funder

National Natural Science Foundation of China

Beijing Municipal Science and Technology Program

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference30 articles.

1. Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia;Apperley;Lancet Oncol,2007

2. Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors;Cortes;Blood,2007

3. Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy;Jabbour;Blood,2008

4. Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I;Velev;Cancer,2010

5. Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia;O'Hare;Blood,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contemporary Role of Hematopoietic Stem Cell Transplantation in the Management of Chronic Myeloid Leukemia: Is It the Same in All Settings?;Cancers;2024-02-12

2. Chronic Myeloid Leukemia in Children and Adolescents;Advances in Pediatrics;2023-08

3. The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2022-06

4. The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation;Hematological Oncology;2022-04-12

5. Precision diagnostics: integration of tissue pathology and genomics in cancer;Pathology;2021-12